Clinical trial exposure to Abilify, Abilify Maintena, and Abilify Maintena The clinical program for Abilify Maintena 720/960 mg prolonged-release
Aripiprazole, a quinolinone derivative which Alternative Names: Abilify; Abilify Asimtufii; ABILIFY MAINTENA; Abilify Maintena; Abilify MyCite; ABILIFY
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
Abilify Maintena contains the active ingredient aripiprazole. Abilify Maintena belongs to a group of medicines called antipsychotic agents. Abilify Maintena
ABILIFY ASIMTUFII and ABILIFY MAINTENA are not for the treatment of people with dementia-related psychosis. Do not receive ABILIFY ASIMTUFII or ABILIFY MAINTENA if you are allergic to aripiprazole or any of the ingredients in ABILIFY ASIMTUFII or ABILIFY MAINTENA. ABILIFY ASIMTUFII or ABILIFY MAINTENA may cause serious side effects, including:
Comments